Matthew Sloan, MD, MSc, FRCPC
Assistant Professor
matthew.sloan@camh.ca
Dr. Sloan is a clinician scientist specializing in the treatment of substance use disorders and their psychiatric comorbidities. He completed medical school and psychiatry residency at McGill University followed by a postdoctoral fellowship in Human Psychopharmacology at the National Institutes of Health and an Addiction Psychiatry fellowship at Yale University. His primary research interests are developing innovative new treatments for substance use disorders and exploring determinants of psychopharmacological response to drugs of abuse. He has obtained competitive funding from CIHR and the CAMH Discovery Fund and has received scientific prizes from the American Academy of Addiction Psychiatry and the National Institute on Alcohol Abuse and Alcoholism.
Areas of Research: Psychopharmacology, Addiction, Endocannabinoid System